PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke

NCT07466251 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

1212

Enrollment

OTHER

Sponsor class

Conditions

Acute Ischemic Stroke AIS
Intracranial Atherosclerosis ICAS
Atherosclerotic Plaque

Interventions

DRUG: Rucacuzumab plus standard therapy
DRUG: Recaticimab plus placebo in combination with standard therapy

Sponsor

Peking Union Medical College Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]